MARKET

BDRX

BDRX

Biodexa Pharmaceuticals plc
NASDAQ
0.9474
+0.0074
+0.79%
Pre Market: 0.9472 -0.0002 -0.02% 08:00 03/06 EST
OPEN
0.9401
PREV CLOSE
0.9400
HIGH
0.9896
LOW
0.9200
VOLUME
1.75K
TURNOVER
79.39M
52 WEEK HIGH
44.40
52 WEEK LOW
0.9000
MARKET CAP
794.67K
P/E (TTM)
-0.0013
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BDRX last week (0223-0227)?
Weekly Report · 4d ago
Weekly Report: what happened at BDRX last week (0216-0220)?
Weekly Report · 02/23 10:01
Biodexa Pharmaceuticals Adds New Phase 1 Ready Candidate To Its Portfolio To Treat Gastrointestinal Stromal Tumors
Benzinga · 02/19 12:33
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 02/17 21:06
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 02/17 17:05
Weekly Report: what happened at BDRX last week (0209-0213)?
Weekly Report · 02/16 10:01
Weekly Report: what happened at BDRX last week (0202-0206)?
Weekly Report · 02/09 10:02
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 02/06 12:05
More
About BDRX
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company. The Company is developing a pipeline of products for the treatment of diseases with unmet medical needs. The Company’s lead development program, eRapa, is under development for familial adenomatous polyposis and non-muscle invasive bladder cancer; tolimidone, under development as a for the treatment of type 1 diabetes; and MTX110, which is being studied in aggressive rare/orphan brain cancer indications, including recurrent glioblastoma, diffuse midline glioma, or DMG, and medulloblastoma. Its technologies include Q-Sphera, MidaCore and MidaSolve. The Q-Sphera platform is a polymer microsphere microtechnology used for sustained delivery to prolong and control the release of therapeutics over an extended period of time, from weeks to months. Its MidaSolve platform is an oligosaccharide nanotechnology that is used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors.

Webull offers Biodexa Pharmaceuticals PLC-ADR stock information, including NASDAQ: BDRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BDRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BDRX stock methods without spending real money on the virtual paper trading platform.